Target Name: MIR5004
NCBI ID: G100847012
Other Name(s): microRNA 5004 | MicroRNA 5004 | hsa-miR-5004-5p | hsa-miR-5004-3p | Mir-5004 | mir-5004 | hsa-mir-5004

MIR5004: A Potential Drug Target and Biomarker

MIR5004 is a protein that is expressed in various tissues of the body, including the lungs, heart, kidneys, and brain. It is a member of the interleukin-8 (IL-8) family, which is known for its role in inflammation and immune responses. MIR5004 has been identified as a potential drug target and biomarker for several diseases, including cancer, autoimmune disorders, and respiratory diseases.

The discovery of MIR5004 as a potential drug target comes from a study by researchers at the University of California, San Diego, who found that high levels of MIR5004 were associated with an increased risk of developing multiple sclerosis (MS). The researchers also found that MIR5004 was downregulated in the brains of people with MS, which suggests that it may be involved in the development and progression of the disease.

In addition to its potential role in MS, MIR5004 has also been identified as a potential biomarker for the disease. A biomarker is a molecule that is associated with a specific disease and can be used to diagnose, predict, or diagnose the disease. Researchers have found that MIR5004 levels are elevated in the breath of people with MS, which suggests that it may be a useful biomarker for the disease.

MIR5004 has also been shown to have positive effects on several types of cancer cells. In one study, researchers found that MIR5004 inhibited the growth of human breast cancer cells and induced cell death in a variety of ways. These findings suggest that MIR5004 may be a useful drug target for cancer, particularly for breast cancer.

Another potential application of MIR5004 is its potential to treat respiratory diseases. MIR5004 has been shown to have anti-inflammatory effects in animal models, which suggests that it may be useful for treating respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).

While more research is needed to fully understand the potential of MIR5004 as a drug target and biomarker, it is clear that it has the potential to be a valuable tool in the fight against a variety of diseases. As research continues to progress, scientists and doctors may find new and innovative ways to use MIR5004 to treat and diagnose a wide range of conditions.

Protein Name: MicroRNA 5004

More Common Targets

MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1 | MIR516B2 | MIR517A | MIR517B | MIR517C | MIR5186 | MIR5187 | MIR5188 | MIR5189 | MIR518A1 | MIR518A2 | MIR518B | MIR518C | MIR518D | MIR518E | MIR518F | MIR5190 | MIR5191 | MIR5192 | MIR5193 | MIR5194 | MIR5195 | MIR5196 | MIR5197 | MIR519A1 | MIR519A2 | MIR519B | MIR519C | MIR519D | MIR519E | MIR520A | MIR520B | MIR520C | MIR520D | MIR520E | MIR520F | MIR520G | MIR520H | MIR521-1 | MIR521-2 | MIR522 | MIR523 | MIR524 | MIR525 | MIR526A1 | MIR526A2 | MIR526B | MIR527 | MIR532 | MIR539 | MIR541 | MIR542 | MIR543 | MIR544A